Blood Type and Coombs' Test
In this newborn with early-onset severe jaundice (within 12 hours), anemia, and reticulocytosis, the most appropriate next investigation is Blood Type and Coombs' Test (Direct Antiglobulin Test). This is not among your listed options A-D, but represents the correct first-line investigation according to established guidelines.
Why Blood Type and Coombs' Test First
The clinical presentation screams immune-mediated hemolysis:
- Jaundice within 12 hours (pathologic, not physiologic)
- Severe anemia (Hgb 91 g/L)
- High reticulocyte count (7% - indicating active hemolysis)
- Extremely elevated bilirubin (2800 µmol/L ≈ 164 mg/dL)
According to the AAP guidelines, for any infant with jaundice in the first 24 hours, blood type and Coombs' test should be obtained if not already done with cord blood 1. The guideline specifically states that for "infant receiving phototherapy or TSB rising rapidly and unexplained by history and physical examination," the first-line workup includes: Blood type and Coombs' test, complete blood count and smear 1.
Immune-mediated hemolysis (ABO or Rh incompatibility) is the most common cause of severe early-onset jaundice with hemolysis, and a positive Coombs' test immediately identifies this life-threatening condition 1.
If Forced to Choose From Your Options (A-D)
If blood type/Coombs' has already been done and is negative, then D. G6PD Activity is the most appropriate next test.
Here's why:
G6PD Deficiency is Critical to Identify
G6PD deficiency was the cause of hyperbilirubinemia in 31.5% (19 of 61) of infants who developed kernicterus 1. This makes it a high-priority diagnosis when immune causes are excluded. The AAP guidelines explicitly recommend G6PD testing when TSB is approaching exchange levels or not responding to phototherapy 1.
Why Not the Other Options?
A. Osmotic Fragility Test (for hereditary spherocytosis): While spherocytosis can cause neonatal jaundice 2, it's much rarer than G6PD deficiency and typically presents less severely. This test is not mentioned in the AAP guidelines for initial workup 1.
B. Pyruvate Kinase Assay: This tests for pyruvate kinase deficiency, an extremely rare enzymopathy. Not part of standard initial evaluation 1.
C. Hemoglobin Electrophoresis: Tests for hemoglobinopathies (sickle cell, thalassemia). While alpha-thalassemia can rarely cause neonatal anemia 3, it's not a priority in the acute setting and doesn't typically cause this degree of early jaundice. Not recommended in AAP guidelines for initial workup 1.
Clinical Algorithm
Step 1: Blood type (infant and maternal) + Direct Coombs' test
- If positive → Immune hemolysis (ABO/Rh incompatibility) confirmed
- If negative → Proceed to Step 2
Step 2: G6PD activity
- Critical because of high kernicterus risk
- Note: G6PD levels may be falsely normal during acute hemolysis; if suspicion remains high, retest at 3 months 1
Step 3: If G6PD normal, consider:
- Complete blood count with smear (look for spherocytes, elliptocytes, fragmented cells)
- Reticulocyte count (already elevated here, confirming hemolysis)
- Further testing: osmotic fragility, pyruvate kinase, hemoglobin electrophoresis based on smear findings
Critical Management Points
This infant requires immediate intensive phototherapy given the bilirubin level of 2800 µmol/L (164 mg/dL) at 36 hours. Exchange transfusion should be strongly considered as this level approaches or exceeds exchange thresholds for a newborn at this age 1.
Common pitfall: Waiting for all test results before initiating treatment. Treatment must begin immediately while diagnostic workup proceeds, as kernicterus risk is imminent at these bilirubin levels 1.
Another pitfall: Assuming a "normal" G6PD level rules out deficiency during acute hemolysis - reticulocytes have higher G6PD activity, potentially masking the diagnosis 1.